|
CLDX Celldex Therapeutics Inc 744218 |
| Balance Sheet |
|
Current Assets
|
$724,931,000.00 |
|
Assets
|
$782,349,000.00 |
|
Current Liabilities
|
$61,325,000.00 |
|
Liabilities
|
$67,785,000.00 |
|
Equity
|
$714,564,000.00 |
|
Shares Out
|
78500173.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-122,998,000.00 |
|
Investing Cash Flow
|
$-183,403,000.00 |
| Market Analysis |
Market Cap
|
$3,135,296,909.62 |
|
Price
|
$39.94 |
|
BVPS
|
9.10 |
|
PB
|
4.39 |
|
EPS
|
-0.94 |
|
PS
|
35628.37 |
|
FCF
|
$-127,816,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:19 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-1.22 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-1.18 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.85 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-1.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLDX documents filed with the SEC.
CLDX Filings
Clear
